Education
About Us
Working with TipRanks
Follow Us
Rapid Micro Biosystems (RPID)
NASDAQ:RPID
RPID Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.80 - $4.50
Previous CloseN/A
Volume19.55K
Average Volume (3M)104.34K
Market Cap
$124.67M
Enterprise Value$128.36M
Total Cash (Recent Filing)$31.25M
Total Debt (Recent Filing)$5.58M
Price to Earnings (P/E)―
Beta0.80
Next Earnings
Nov 06, 2025EPS Estimate
-0.25Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.27
Shares Outstanding39,710,800
10 Day Avg. Volume132,535
30 Day Avg. Volume104,342
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap1.03
Enterprise Value/Revenue4.24
Enterprise Value/Gross Profit22.41
Enterprise Value/Ebitda-2.92
Forecast
1Y Price Target
$5.25Price Target Upside100.38% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
Bulls Say, Bears Say
Bulls Say
Customer AdoptionA 2023 Company-led survey of 146 pharma professionals found 93% were open to adopting Rapid Microbial Methods, citing faster batch release, reduced manual labor, and improved integration with workflows.
Market LeadershipRapid Micro Biosystems is emerging as the category leader in microbial quality control automation with its Growth Direct platform, a system that compresses testing timelines from weeks to days, reduces contamination risk, and ensures compliance with increasingly strict regulatory requirements.
Recurring RevenueRecurring revenue now represents over 55% of total revenue, which includes consumables that carry a ~60% gross margin.
Bears Say
Spending UncertaintySpending uncertainty and tariff impact are driving expectations toward the lower end of 21-25 placements.
Stock Market ReactionThe selloff following the Q2 print is viewed as underappreciating the strong growth outlook for Rapid with multiple avenues to outperform.
Rapid Micro Biosystems News
RPID FAQ
What was Rapid Micro Biosystems’s price range in the past 12 months?
Rapid Micro Biosystems lowest stock price was $0.80 and its highest was $4.50 in the past 12 months.
What is Rapid Micro Biosystems’s market cap?
Rapid Micro Biosystems’s market cap is $124.67M.
When is Rapid Micro Biosystems’s upcoming earnings report date?
Rapid Micro Biosystems’s upcoming earnings report date is Nov 06, 2025 which is in 82 days.
How were Rapid Micro Biosystems’s earnings last quarter?
Rapid Micro Biosystems released its earnings results on Aug 12, 2025. The company reported -$0.27 earnings per share for the quarter, missing the consensus estimate of -$0.253 by -$0.017.
Is Rapid Micro Biosystems overvalued?
According to Wall Street analysts Rapid Micro Biosystems’s price is currently Undervalued.
Does Rapid Micro Biosystems pay dividends?
Rapid Micro Biosystems does not currently pay dividends.
What is Rapid Micro Biosystems’s EPS estimate?
Rapid Micro Biosystems’s EPS estimate is -0.25.
How many shares outstanding does Rapid Micro Biosystems have?
Rapid Micro Biosystems has 39,710,800 shares outstanding.
What happened to Rapid Micro Biosystems’s price movement after its last earnings report?
Rapid Micro Biosystems reported an EPS of -$0.27 in its last earnings report, missing expectations of -$0.253. Following the earnings report the stock price went down -17.791%.
Which hedge fund is a major shareholder of Rapid Micro Biosystems?
Currently, no hedge funds are holding shares in RPID
Rapid Micro Biosystems Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$5.25 (100.38% Upside)
$5.25 (100.38% Upside)
Blogger Sentiment
Bullish
RPID Sentiment 100%
Sector Average 70%
Sector Average 70%
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.2%
Last 30 Days ▼ 2.5%
Last 30 Days ▼ 2.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
215.66%
12-Months-Change
Fundamentals
Return on Equity
-59.15%
Trailing 12-Months
Asset Growth
-35.44%
Trailing 12-Months
Company Description
Rapid Micro Biosystems
Rapid Micro Biosystems (RPID) is a biotechnology company specializing in the development and commercialization of innovative products for the detection of microbial contamination in the production of pharmaceuticals, biotechnology products, and personal care products. The company's core products include automated, non-destructive microbial detection systems that provide rapid and accurate results, enabling manufacturers to ensure product safety and quality while streamlining their quality control processes.
RPID Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call emphasized strong revenue growth and significant improvements in service revenue and gross margins. However, challenges remain with high operating expenses, negative product margins, and a substantial net loss. The collaboration with MilliporeSigma and customer demand for GrowthDirect provide a positive outlook, though macroeconomic uncertainties persist.View all RPID earnings summariesRPID Stock 12 Month Forecast
Average Price Target
$5.25
▲(100.38% Upside)
Technical Analysis
Ownership Overview
5.13% Insiders
2.66% Mutual Funds
30.59% Other Institutional Investors
59.13% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---